Transcription Factor Decoys for the Prevention of Vein Bypass Graft Failure
Therapeutic Potential of Platelet Glycoprotein IIb/IIIa Receptor Antagonists in the Management of Ischemic Stroke
Atrial Fibrillation in Patients After Cardiovascular Surgery
The Use of Roxifiban (DMP754), a Novel Oral Platelet Glycoprotein IIb/IIIa Receptor Inhibitor, in Patients with Stable Coronary Artery Disease
Spotlight on Ramipril in the Prevention of Cardiovascular Outcomes1
Cilostazol
Opinion and Evidence in Cardiovascular Therapeutics